These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28059036)

  • 1. Reduction of Doxorubicin-Induced Cardiotoxicity Using Nanocarriers: A Review.
    Fojtu M; Gumulec J; Stracina T; Raudenska M; Skotakova A; Vaculovicova M; Adam V; Babula P; Novakova M; Masarik M
    Curr Drug Metab; 2017; 18(3):237-263. PubMed ID: 28059036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical Measures to Prevent Doxorubicin-Induced Cardiotoxicity.
    Liu H; Wang H; Xiang D; Guo W
    Mini Rev Med Chem; 2017; 17(1):44-50. PubMed ID: 27337969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-induced cardiotoxicity is suppressed by estrous-staged treatment and exogenous 17β-estradiol in female tumor-bearing spontaneously hypertensive rats.
    Pokrzywinski KL; Biel TG; Rosen ET; Bonanno JL; Aryal B; Mascia F; Moshkelani D; Mog S; Rao VA
    Biol Sex Differ; 2018 Jun; 9(1):25. PubMed ID: 29907135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin conjugates: a practical approach for its cardiotoxicity alleviation.
    Ibrahim AA; Nsairat H; Al-Sulaibi M; El-Tanani M; Jaber AM; Lafi Z; Barakat R; Abuarqoub DA; Mahmoud IS; Obare SO; Aljabali AAA; Alkilany AM; Alshaer W
    Expert Opin Drug Deliv; 2024 Mar; 21(3):399-422. PubMed ID: 38623735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in nano-delivery systems for doxorubicin: an updated insight.
    Kanwal U; Irfan Bukhari N; Ovais M; Abass N; Hussain K; Raza A
    J Drug Target; 2018 Apr; 26(4):296-310. PubMed ID: 28906159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes.
    Tahover E; Patil YP; Gabizon AA
    Anticancer Drugs; 2015 Mar; 26(3):241-58. PubMed ID: 25415656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
    Seymour L; Bramwell V; Moran LA
    Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel self-assembly albumin nanocarrier for reducing doxorubicin-mediated cardiotoxicity.
    Yuan A; Wu J; Song C; Tang X; Qiao Q; Zhao L; Gong G; Hu Y
    J Pharm Sci; 2013 May; 102(5):1626-35. PubMed ID: 23423631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products.
    Yu J; Wang C; Kong Q; Wu X; Lu JJ; Chen X
    Phytomedicine; 2018 Feb; 40():125-139. PubMed ID: 29496165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value.
    Skubitz KM; Blaes AH; Konety SH; Francis GS
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):787-798. PubMed ID: 28856562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.
    Galal A; El-Bakly WM; Al Haleem EN; El-Demerdash E
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):309-22. PubMed ID: 26676227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-induced Cardiotoxicity and Cardioprotective Agents: Classic and New Players in the Game.
    Dos Santos Arruda F; Tomé FD; Miguel MP; de Menezes LB; Nagib PRA; Campos EC; Soave DF; Celes MRN
    Curr Pharm Des; 2019; 25(2):109-118. PubMed ID: 30864503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo.
    Cote B; Carlson LJ; Rao DA; Alani AWG
    J Control Release; 2015 Sep; 213():128-133. PubMed ID: 26160305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin.
    Berry G; Billingham M; Alderman E; Richardson P; Torti F; Lum B; Patek A; Martin FJ
    Ann Oncol; 1998 Jul; 9(7):711-6. PubMed ID: 9739435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity.
    Koleini N; Kardami E
    Oncotarget; 2017 Jul; 8(28):46663-46680. PubMed ID: 28445146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microformulations and Nanoformulations of Doxorubicin for Improvement of Its Therapeutic Efficiency.
    Alavi M; Nokhodchi A
    Crit Rev Ther Drug Carrier Syst; 2020; 37(6):591-611. PubMed ID: 33426834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways.
    Wang A J; Zhang J; Xiao M; Wang S; Wang B J; Guo Y; Tang Y; Gu J
    Cell Mol Life Sci; 2021 Apr; 78(7):3105-3125. PubMed ID: 33438055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyphenols, autophagy and doxorubicin-induced cardiotoxicity.
    Shabalala S; Muller CJF; Louw J; Johnson R
    Life Sci; 2017 Jul; 180():160-170. PubMed ID: 28478263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes.
    Working PK; Newman MS; Sullivan T; Yarrington J
    J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.